In SCLC, lncRNA LYPLAL1‐DT acts as an oncogenic lncRNA, which negatively regulates miR‐204‐5p leading to the upregulation of PFN2, promoting cell proliferation, migration and invasion [63]. The gene discussed is LYPLAL1; the disease is small cell lung carcinoma.